Jean-Luc Girardet, Chief Technical Officer
Professional Overview
Jean-Luc Girardet is a seasoned pharmaceutical executive with over 20 years of experience in the industry. As the Chief Technical Officer at Mirum Pharmaceuticals, Inc., he is responsible for leading the company's technical and scientific strategy, ensuring the successful development and commercialization of innovative drug candidates.
Experience Summary
Current Role
As the Chief Technical Officer at Mirum Pharmaceuticals, Inc. since April 2022, Jean-Luc Girardet is instrumental in advancing the company's pharmaceutical pipeline. In this role, he oversees all aspects of pharmaceutical sciences, including formulation development, analytical method development, and process engineering. He also plays a key role in guiding the company's regulatory submissions and interactions with global health authorities.
Career Progression
Prior to joining Mirum Pharmaceuticals, Jean-Luc held various leadership positions in the pharmaceutical industry. He served as the Senior Vice President of Pharmaceutical Sciences at Brii Biosciences from 2018 to 2022, where he successfully led the development and scale-up of multiple clinical-stage drug candidates. Before that, he was the Vice President at Ardea Biosciences, Inc., a member of the AstraZeneca Group, from 2007 to 2018, where he made significant contributions to the advancement of several pipeline assets.
Earlier in his career, Jean-Luc held roles as Associate Director at Valeant Pharmaceuticals and Principal Scientist at Ribapharm and ICN Pharmaceuticals, demonstrating his breadth of experience in the pharmaceutical industry.
Academic Background
Jean-Luc Girardet holds a Ph.D. in Pharmaceutical Sciences from the University of Southern California, where he specialized in formulation development and drug delivery systems. His academic achievements and research contributions have been recognized through numerous publications in peer-reviewed journals.
Areas of Expertise
- Pharmaceutical product development and scale-up
- Analytical method development and validation
- Regulatory strategy and interactions with global health authorities
- Formulation development for small molecule and biologic drug candidates
- Process engineering and optimization
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Jean-Luc Girardet has demonstrated a track record of successfully guiding the development and commercialization of innovative pharmaceutical products. His technical expertise, coupled with his strategic leadership, has been instrumental in advancing multiple drug candidates through various stages of clinical development. Jean-Luc's contributions have had a significant impact on the pharmaceutical industry, and he is recognized as a respected and influential technical leader.
Conclusion
With his extensive experience, technical expertise, and proven record of success, Jean-Luc Girardet is well-positioned to lead Mirum Pharmaceuticals' technical and scientific strategy, driving the company's efforts to bring novel therapies to patients in need.
